251
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Endothelial pyroptosis underlies systemic inflammatory response following radiofrequency ablation of hepatic hemangiomas

, , , , , , & show all
Pages 619-628 | Received 03 Jun 2019, Accepted 02 Nov 2019, Published online: 11 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Changyu Yao, Jian Kong, Fei Xu, Shaohong Wang, Shilun Wu, Wenbing Sun & Jun Gao. (2024) Heme-Inducing Endothelial Pyroptosis Plays a Key Role in Radiofrequency Ablation of Hepatic Hemangioma Leading to Systemic Inflammatory Response Syndrome. Journal of Inflammation Research 17, pages 371-385.
Read now
Dishiwen Liu, Yajia Li & Qingyan Zhao. (2023) Effects of Inflammatory Cell Death Caused by Catheter Ablation on Atrial Fibrillation. Journal of Inflammation Research 16, pages 3491-3508.
Read now

Articles from other publishers (10)

Jushang Li, Shuaiguo Zhang, Chunmin Ning, Guoming Li & Shigang Guo. (2024) Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas. European Journal of Gastroenterology & Hepatology.
Crossref
Arkadiusz Kacała, Mateusz Dorochowicz, Iwona Matus, Michał Puła, Adrian Korbecki, Michał Sobański, Jagoda Jacków-Nowicka, Dariusz Patrzałek, Dariusz Janczak & Maciej Guziński. (2024) Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies. Medicina 60:3, pages 449.
Crossref
Arkadiusz Kacała, Mateusz Dorochowicz, Adrian Korbecki, Michał Sobański, Michał Puła, Dariusz Patrzałek, Dariusz Janczak & Maciej Guziński. (2024) Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness. Cancers 16:2, pages 380.
Crossref
鸿钰 褚. (2024) Research Progress on the Complications of Radiofrequency Ablation in the Treatment of Giant Hepatic Hemangiomas. Advances in Clinical Medicine 14:01, pages 2041-2047.
Crossref
Lu Yu, Min Cheng, Jie Liu, Xin Ye, Zhigang Wei, Jiamei Xu, Qi Xie & Jing Liang. (2023) Crosstalk between microwave ablation and ferroptosis: The next hot topic?. Frontiers in Oncology 13.
Crossref
Meixiang Wang, Zhigang Wei & Xin Ye. (2022) Issues and prospects of image‐guided thermal ablation in the treatment of primary and metastatic lung tumors. Thoracic Cancer 14:1, pages 110-115.
Crossref
Bing Yuan, Jin-Long Zhang, Feng Duan & Mao-Qiang Wang. (2022) Medium and Long-Term Outcome of Superselective Transcatheter Arterial Embolization with Lipiodol–Bleomycin Emulsion for Giant Hepatic Hemangiomas: Results in 241 Patients. Journal of Clinical Medicine 11:16, pages 4762.
Crossref
Xiang Wei, Feng Xie, Xiaoxue Zhou, Yuchen Wu, Haiyan Yan, Ting Liu, Jun Huang, Fangwei Wang, Fangfang Zhou & Long Zhang. (2022) Role of pyroptosis in inflammation and cancer. Cellular & Molecular Immunology 19:9, pages 971-992.
Crossref
Aldo Carnevale, Fabio Pellegrino, Alberto Cossu, Anna Maria Ierardi, Gian Carlo Parenti, Gianpaolo Carrafiello & Melchiore Giganti. (2020) Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary. Medical Oncology 37:4.
Crossref
Zhaodi Zheng & Guorong Li. (2020) Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer. International Journal of Molecular Sciences 21:4, pages 1456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.